Page last updated: 2024-12-08

3-hydroxyhexanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hydroxyhexanoic acid: abnormal metabolite in urine & serum of diabetic ketoacidotic patients [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151492
CHEBI ID37035
SCHEMBL ID20843
MeSH IDM0131202

Synonyms (32)

Synonym
CHEBI:37035
3-hydroxycaproic acid
3-hydroxyhexanoic acid
10191-24-9
dl-3-hydroxy caproic acid
LMFA01050012
3-hydroxy-hexanoic acid
(+/-)-3-hydroxyhexanoic acid
FT-0669373
EN300-79913
unii-48nux22xxo
48nux22xxo ,
hexanoic acid, 3-hydroxy-
AKOS011682999
SCHEMBL20843
3-hydroxyhexanoic acid, (+/-)-
fema no. 5005
.beta.-hydroxycaproic acid
.beta.-hydroxyhexanoic acid
J-000518
mfcd02259045
racemic 3-hydroxyhexanoic acid
3-hydroxy hexanoic acid
HPMGFDVTYHWBAG-UHFFFAOYSA-N
E77200
Q27117019
BS-52133
3-hydroxy c6:0 fatty acid
DTXSID40906794
3-hydroxyhexanoicacid
PD078037
Z982132146

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Those with positive surface charges were found to be more toxic than those with negative surface charges."( Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells.
Cai, XX; Hao, LY; Lin, YF; Peng, Q; Shao, XR; Song, X; Wei, XQ; Zhang, ZR, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
3-hydroxy monocarboxylic acidA hydroxy monocarboxylic acid that has a hydroxy group beta to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.17)18.7374
1990's1 (2.17)18.2507
2000's13 (28.26)29.6817
2010's21 (45.65)24.3611
2020's10 (21.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.61 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.79 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.35%)6.00%
Case Studies1 (2.17%)4.05%
Observational0 (0.00%)0.25%
Other43 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]